Scalper1 News
French big pharma Sanofi laid out its seven-year plan for drug launches, which it says will bring in a cumulative 30 billion euros ($37.6 billion) in their first five years of sales. But Sanofi stock slipped 3% in early trading on the stock market today, as its diabetes outlook was soft. Sanofi (SNY) issued its update in a press release ahead of its IR Thematic Seminar on New Medicines, in which it sought to reassure investors after it fired its Scalper1 News
Scalper1 News